The global lyophilization market size is projected to reach US$ 988.8 Million in 2022. Increasing adoption of lyophilization services for the production of pharmaceutical and biopharmaceutical products is expected to push sales at a robust 8.8% CAGR over the assessment period (2022-2032).
Rising awareness regarding the beneficial aspects of lyophilization process, along with technological advancements in freeze drying equipment will drive sales in the market. The process effectively increases the shelf life of pharmaceutical and biopharmaceutical products. Manufacturers are using lyophilization for vaccines, antibodies, and peptides.
The process also removed moisture when the product goes through three stages of the process, freezing, primary drying, and secondary drying. This stabilizes pharmaceutical formulations and increases the temperature tolerance in biopharmaceutical products.
As temperature control and stability are crucial aspects of various pharmaceutical formulations, the adoption of lyophilization is expected to increase at a considerable pace. Manufacturers are launching freeze dryers that can efficiently optimize the shelf temperature and chamber pressure to maintain the quality of the product. This equipment also maximizes the sublimation rate, further enhancing the stability of formulations.